Recently, the review of [37] shows that the changes in the expression or activity of calcium channels and pumps are relevant for the pathology of cancers (patient samples and cell lines) for instance, in prostate cancer: TRPM8, TRPV6, ORAI1, TRPV2; breast cancer: TRPM8, TRPV6, TRPC6, PMCA1, PMCA2, SPCA2, ORAI1, ORAI3; lung cancer: IP3R2, CACNA2D2, TRPM8, PMCA, SERCA2; colon/colorectal: Cav. This evidence concerns the gene TRPV6 and prostate carcinoma.